test44
https://www.cytel.com/blog/myths-surrounding-the-use-of-synthetic-control-arms-in-clinical-trials-part-4
July 1, 2021
Synthetic control arms (SCAs) are best suited for situations when a single arm trial is run in a patient population..
Read article
test44
https://www.cytel.com/blog/career-perspectives-interview-with-neha-sati
April 7, 2021
Scientists at Cytel recently published a paper in the Journal of the American Medical Association (JAMA). Among the..
Read article
test44
https://www.cytel.com/blog/using-bayesian-networks-to-predict-survival-outcomes-new-case-study
April 2, 2021
Earlier this month, my colleagues at Cytel Canada published a paper in JCO Clinical Cancer Informatics, offering a..
Read article
test44
https://www.cytel.com/blog/data-and-analysis-in-modern-oncology-clinical-development
March 11, 2021
In the recent years, Oncology trials are seeing a technological shift that is expected to make them faster and more..
Read article
test44
https://www.cytel.com/blog/single-arm-multi-stage-phase-2-cancer-trials-reviewing-essential-new-designs
March 5, 2021
Early stage Phase 2 clinical trials are often designed as multi-stage single arm trials, which quickly identify..
Read article
test44
https://www.cytel.com/blog/leveraging-synthetic-and-external-control-arms-using-bayesian-methods
February 12, 2021
In recent times, Single arm trials are being increasingly used to assess new treatment interventions. They establish..
Read article
test44
https://www.cytel.com/blog/new-meta-analysis-in-jama-uses-novel-quantitative-techniques-to-demonstrate-baseline-characteristics-informing-response-to-common-therapy-for-kidney-cancer
February 9, 2021
Recent years have witnessed improving survival outcomes for those struggling with a range of common kidney cancers...
Read article
test44
https://www.cytel.com/blog/cytel-and-ingress-health-at-virtual-ispor-europe-2020
November 24, 2020
Virtual ISPOR 2020, held November 16 to 19, presented new opportunities for scientific interaction amongst HEOR..
Read article
test44
https://www.cytel.com/blog/bayesian-methods-for-multiple-cohort-expansion-design
November 16, 2020
MUCE is a Bayesian solution for cohort expansion trials where multiple dose(s) and multiple indication(s) are tested in..
Read article
